Founded Date: 2009
Last Funding Type: Venture - Series Unknown
Headquarters: Ann Arbor, Michigan, United States
Investors Number: 12
Technology: Neurological Disorders
Industry: Gene Therapy
Estimated Revenue: Less than $1M
Funding Status: M&A
Total Funding: $106M